Forgot your password?
Haven't registered yet?
12 hours agoStewardship / Resistance Scan for Jan 20, 2017
12 hours agoNews Scan for Jan 20, 2017
12 hours agoUS flu numbers rise as 2 more pediatric deaths noted
The upcoming calendar is currently empty.
Click here to view past events and photos »
Pfizer Inc said on Tuesday the U.S. Food and Drug Administration had expanded the use of its best-selling pneumonia vaccine, Prevnar, to adults aged 18 through 49.
The vaccine, which is already approved for use in adults aged 50 and above, and children aged 6 weeks to 17 years, prevents invasive diseases caused by 13 Streptococcus pneumoniae strains.
OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2016. Sponsorship does not imply endorsement by OSAP of a company's products or services.